跳至主要内容
临床试验/NCT01489683
NCT01489683已完成不适用

Effect of Tracheal Lidocaine on Intubating Conditions During Propofol-remifentanil TCI Without Neuromuscular Blockade

Ajou University School of Medicine1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2011年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Overall acceptable conditions for tracheal intubation

研究概览

简要总结

When not using neuromuscular blocking agent, even at optimal dosage, target-controlled infusion (TCI) of propofol and remifentanil occasionally produce unsatisfactory intubating conditions. Therefore, the investigators evaluated that the effect of tracheal lidocaine on the intubating conditions for tracheal intubation during anesthesia induction of propofol and remifentanil TCI without neuromuscular blocking agent in day-case anesthesia.

详细描述

Anesthesia was induced with propofol-remifentanil TCI with the effect-site concentration of 5μg/ml and 5ng/ml, respectively. After TCI, 3 ml of normal saline or 3 ml of 4% lidocaine was instilled to larynx and trachea, following intubation was performed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • ASA I, II patients undergoing general anesthesia for reduction of nasal bone fracture

排除标准

  • bronchial asthma,
  • hypertension,
  • anticipated difficult airway

研究组 & 干预措施

control

Experimental

3 ml of normal saline was instilled to larynx and trachea

干预措施: lidocaine (Drug)

lidocaine

Active Comparator

3 ml of 4% lidocaine was instilled to larynx and trachea before endotracheal intubation

干预措施: normal saline (Drug)

结局指标

主要结局

Overall acceptable conditions for tracheal intubation

时间窗: baseline from 5 min of TCI was maintained

Four minutes after start of propofol-remifentanil TCI, 3 ml of normal saline or 3 ml of 4% lidocaine was instilled to larynx and trachea, and one minute later, intubation was performed in double-blinded fashion.

次要结局

未报告次要终点

研究者

发起方
Ajou University School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jong Yeop Kim

Associate professor

Ajou University School of Medicine

研究点 (1)

Loading locations...

相似试验

Intubating Conditions During Propofol-remifentanil... | 临床试验